| Literature DB >> 32160864 |
Daša Podgoršek1, Eva Ružić-Sabljić1, Mateja Logar2, Andrea Pavlović3, Tatjana Remec4, Zvonko Baklan5, Emil Pal6, Tjaša Cerar7.
Abstract
BACKGROUND: Different diagnostic methods have been used for the laboratory confirmation of leptospirosis. Molecular diagnostic techniques are not only faster and more sensitive than culture analysis, but can also detect a Leptospira infection before the appearance of antibodies. The aim of the present study was to analyze and compare two different PCR approaches applied to blood and urine specimens obtained from patients with clinical manifestations that were suggestive of leptospirosis. Furthermore, the results of these different PCR approaches were compared with the results of culture and serology analyses.Entities:
Keywords: Leptospira; Leptospirosis; Lipl32; PCR
Mesh:
Substances:
Year: 2020 PMID: 32160864 PMCID: PMC7066766 DOI: 10.1186/s12866-020-01744-4
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Results for the detection of leptospiral DNA using conventional PCR and RT-PCR across 400 samples of either blood or urine
| Conventional PCR | RT PCR | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Blood | Urine | Blood & Urine | |||||||
| Pos (%) | Neg (%) | All (%) | Pos (%) | Neg (%) | All | Pos (%) | Neg (%) | All | |
| Pos | 16 (6.8) | 0 | 16 (6.8) | 9 (5.4) | 2 (1.2) | 11 (6.6) | 25 (6.3) | 2 (0.5) | 27 (6.8) |
| Neg | 15 (6.4) | 203 (86.8) | 218 (93.2) | 7 (4.2) | 148 (89.2) | 155 (93.4) | 22 (5.5) | 351 (87.7) | 373 (93.2) |
| All | 31 (13.2) | 203 (86,8) | 234 (100) | 16 (9.6) | 150 (90.4) | 166 (100) | 47 (11.8) | 353 (88.2) | 400 (100) |
| p (Chi sq) | 0.0003 | 0.1824 | 0.0001 | ||||||
| Kappa | 0.6492 | 0.6383 | 0.6453 | ||||||
Patients (Pt) who were positive according to at least one of the three conventional PCR assays or according to RT-PCR, including results from conventional PCR product sequence analysis, and from culture and serology (i.e. microscopic agglutination test [MAT] on blood) analyses
| Pt | Sample | Conventional PCR | RT-PCR | Culture | MAT | ||||
|---|---|---|---|---|---|---|---|---|---|
| LeptoA/B | L3/4 | L4/ LPato2 | Final result | Product sequence analysis | |||||
| 1 | blood | posa | neg | posa | pos | a | pos | neg | Pos 1600 Sejroe |
| 1 | urine | posa | neg | posa | pos | a | pos | neg | |
| 2 | urine | pos | neg | pos | pos | NT | pos | neg | neg |
| 3 | urine | pos | neg | pos | pos | NT | pos | pos | Pos 1600 Icterohaemorrhaiae |
| 4 | urine | pos | neg | pos | pos | NT | pos | neg | Pos 600 Australis |
| 5 | blood | neg | neg | neg | neg | NT | pos | neg | Pos 25,600 Cynopteri |
| 6 | blood | pos | neg | pos | pos | NT | pos | neg | neg |
| 7 | blood | pos | neg | pos | pos | NT | pos | neg | Pos 100 Australis |
| 8 | blood | neg | neg | neg | neg | NT | pos | neg | Pos 102,400 Tarassovi |
| 9 | blood | neg | neg | neg | neg | NT | pos | neg | neg |
| 10 | urine | posa | neg | posa | pos | a | neg | neg | neg |
| 11 | blood | neg | neg | neg | neg | NT | pos | neg | Pos 1600 Sejroe |
| 12 | blood | posa | neg | posa | pos | a | pos | neg | Neg |
| 13 | urine | neg | neg | posa | neg | a | pos | NT | Neg |
| 14 | blood | neg | neg | neg | neg | NT | pos | neg | Pos 800 Australis |
| 15 | blood | neg | neg | posa | neg | a | pos | pos | Pos 200 Canicola |
| 16 | blood | posa | neg | posa | pos | a | pos | neg | neg |
| 16 | urine | posa | neg | posa | pos | a | pos | neg | neg |
| 17 | blood | neg | neg | posa | neg | a | pos | pos | NT |
| 18 | blood | pos | neg | pos | pos | NT | pos | pos | Pos 400 Grippotyphosa |
| 19 | blood | pos | neg | pos | pos | NT | pos | NT | neg |
| 20 | blood | neg | neg | neg | neg | NT | pos | neg | Pos 200 Australis |
| 20 | urine | neg | neg | neg | neg | NT | pos | neg | |
| 21 | blood | neg | neg | neg | neg | NT | pos | NT | NT |
| 22 | blood | neg | neg | posa | neg | a | pos | NT | NT |
| 23 | blood | pos | neg | pos | pos | NT | pos | NT | neg |
| 23 | urine | pos | neg | pos | pos | NT | pos | NT | |
| 24 | urine | posa | neg | posa | pos | a | pos | pos | Pos 400 Sejroe |
| 24 | blood | posa | neg | posa | pos | a | pos | pos | |
| 25 | blood | neg | neg | posa | neg | a | pos | NT | Pos 200 Grippotyphosa |
| 26 | blood | neg | neg | posa | neg | a | pos | neg | Pos 200 Australis |
| 27 | blood | posa | neg | posa | pos | a | pos | neg | neg |
| 28 | urine | neg | neg | neg | neg | NT | pos | neg | neg |
| 29 | blood | neg | neg | neg | neg | NT | pos | neg | Pos 3200 Copenhageni |
| 30 | blood | neg | neg | neg | neg | NT | pos | pos | neg |
| 31 | urine | neg | neg | neg | neg | NT | pos | neg | Pos 400 Panama |
| 32 | blood | neg | neg | neg | neg | NT | pos | pos | NT |
| 33 | blood | posa | neg | posa | pos | a | pos | pos | neg |
| 34 | blood | pos | neg | pos | pos | NT | pos | neg | neg |
| 34 | urine | pos | neg | pos | pos | NT | pos | neg | |
| 35 | blood | pos | neg | pos | pos | NT | pos | neg | neg |
| 36 | blood | posa | neg | posa | pos | a | pos | neg | neg |
| 37 | urine | neg | neg | posa | neg | a | pos | neg | Pos 3200 Sejroe |
| 38 | urine | pos | neg | pos | pos | NT | pos | neg | Pos 800 Grippotyphosa |
| 39 | blood | pos | neg | pos | pos | NT | pos | pos | Pos 1600 Icterohaemorrhaiae |
| 40 | urine | neg | neg | neg | neg | NT | pos | neg | Pos 200 Australis |
| 41 | blood | pos | neg | pos | pos | NT | pos | neg | neg |
| 41 | urine | neg | neg | neg | neg | NT | pos | neg | |
| 42 | urine | posa | neg | posa | pos | a | neg | neg | neg |
NT not tested
a Conventional PCR products subjected to sequence analysis
Primers and probe sequences for polymerase chain reactions (PCR) performed in the study
| Primer | Sequence |
|---|---|
| L3 | 5′ – TgA ggg TTA AAA CCC CCA AC – 3` |
| L4 | 5′ – gAT TTT TCg ggT AAA gAT T – 3` |
| LeptoA | 5′ – ggC gCg TCT TAA ACA Tg – 3` |
| LeptoB | 5′ – TTC CCC CCA TTg AgC AAg ATT – 3` |
| LPato2 | 5′ – TCA CAT Y gCT TAT TTT – 3` |
| LipL32-45F | 5′ – AAg CAT TAC CgC TTg Tgg Tg – 3’ |
| LipL32-286R | 5′ – gAACTCCCATTTCAgCgATT – 3’ |
| Probe LipL32-189P | 5′ – LC610-AAA gCC Agg ACA AgC gCC g--BHQ2–3’ |
Protocols used for conventional PCR and RT-PCR
| Stage | PCR | RT-PCR | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initial denaturation | 93 | 3 | 1 | 93 | 3 | 1 | 93 | 3 | 1 | 600 | ||
| Denaturation | 93 | 1 | 35 | 93 | 1 | 35 | 93 | 1 | 35 | 95 | 15 | 45 |
| Annealing | 60 | 1 | 57 | 1 | 52 | 1 | 53 | 10 | ||||
| Elongation | 72 | 1 | 72 | 1 | 72 | 1 | 72 | 10 | ||||
| Final elongation | 72 | 9 | 1 | 72 | 9 | 1 | 72 | 9 | 1 | 40 | 30 | 1 |
| Hold | 4 | 4 | 4 | |||||||||